Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis

Clinical trial NCT03942887 · UNKNOWN

Trial details

NCT number: NCT03942887
Sponsor: Leiden University Medical Center
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

ANCA Associated Vasculitis

Start date: 2019-05-03
Primary completion: 2025-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.